Developer docs
API playgroundTry for free, no card

Search company profiles

Pelagia AS

Full company profile

uuid00091pe

Namestring
Pelagia AS
Legal namestring
Pelagia Holding AS
Websiteurl
pelagia.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Pelagia AS is a privately held Norwegian seafood company headquartered in Bergen that processes pelagic fish and manufactures fishmeal, marine oils, and protein concentrates across three integrated divisions: Pelagia Food (14 processing facilities producing fresh, frozen, and marinated herring, mackerel, capelin, and silversmelt for export); Pelagia Feed (fishmeal, marine oils, and protein concentrates for aquaculture and animal feed, including Pro-Allo meal and H-Oil Salmon Oil); and Pelagia Health (premium marine lipid ingredients under the EPAX brand for dietary supplements and pharmaceuticals, including the 2025-launched EPAX Evolve 05, the world's first commercially available VLC-PUFA product). The company applies a 100% fish utilization, zero-waste philosophy and operates from 46 locations across five countries (Norway, Denmark, UK, Ireland, and additional markets) with approximately 1,700 employees.

Pelagia's competitive position rests on proprietary process technology including the EQP+Tech molecular distillation platform (maintaining 90%+ triglyceride content without excessive heat or harsh chemicals, backed by data from over a thousand test runs), custom re-esterification with sensors monitoring thousands of data points, Pro-Allo fishmeal with over 32% water-soluble protein content, and high-temperature heat pump drying technology that reduces energy use by approximately 70% at the Måløy facility. Regulatory credentials include US FDA Pharmaceutical Intermediates approval, Norwegian Medicines Agency API production approval, and GMP+ FSA plus MarinTrust certifications across multiple feed products. The company invests in research partnerships (Nofima, SINTEF) and industrial decarbonization collaborations (Enerin, Swedish Exergy).

The business model is B2B wholesale across four primary vertical segments (fisheries, aquaculture, food processing, and health/nutraceutical), with sales managed by regional sales managers in Norway, the UK, and international markets through quote-based pricing. Revenue is generated through one-time license/sale of physical marine ingredient products, with distribution through direct sales channels and global export of seafood products. Capital structure reflects an active acquisition strategy (Ideal Foods in March 2024, Blue Ocean Technology consolidated by June 2024, Fjord Solutions in June 2025) and two consecutive NOK 1,000 million senior unsecured bond issuances in 2024 and 2025 applied for listing on Oslo Børs.

Short descriptiontext

Pelagia AS is a privately held Norwegian seafood processor with three integrated divisions: Food (14 pelagic fish processing facilities), Feed (fishmeal and marine oils), and Health (EPAX omega-3 concentrates). It serves B2B customers across fisheries, aquaculture, food processing, and nutraceutical industries in five countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersBergen, Norway
HQ citystring
Bergen
HQ countrystring
Norway
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pelagic fish processing, fishmeal production, marine oil refining, omega-3 concentrates, aquaculture feed ingredients
Industry4 codes
1Seafood By-Products & Fishmeal/Fish Oil Processing (Rendering, Hydrolysates, Collagen)
CodeAFANADAJPrimaryYes
2Finfish Feed (Salmonids, Trout, Sea Bass/Bream, Tilapia, Catfish)
CodeAFADADAAPrimaryNo
3Aquaculture Feed & Nutrition
CodeHLAMAHAFPrimaryNo
4Smoked, Cured & Salted Seafood (Lox, Kippers, Bacalao)
CodeAFANADAFPrimaryNo
NAICS code1 code
  • Seafood Product Preparation and Packaging3117
SIC code2 codes
  • Prepared Fresh Or Frozen Fish & Seafoods2092
  • Fats & Oils2070
Product category
Seafood Processing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pelagia Food - Pelagic Seafood Products
TypeOne Time License
Description

Processing and export of pelagic fish including herring, mackerel, capelin, and silversmelt in fresh, frozen, and marinated forms. 14 processing facilities in Norway and Northern Europe ensuring freshness and high quality.

pelagia.com
2Pelagia Feed - Fishmeal and Marine Oils
TypeOne Time License
Description

Production of fish meal, marine oils, and protein concentrates for aquafeed and animal feed applications. Includes Pro-Allo meal, marine protein, and liquid protein products for aquaculture.

pelagia.com
3Pelagia Health - EPAX Omega-3 Products
TypeOne Time License
Description

Premium-quality marine ingredients for dietary supplements and pharmaceuticals under the EPAX brand. Includes ultra-concentrated omega-3, VLC-PUFA products, and specialty fatty acid ingredients for nutraceutical applications.

pelagia.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Pro-Allo Meal
Description

A breakthrough fishmeal optimized to improve feed efficiency, fish health, and survival rates in aquaculture, with over 32% water-soluble protein content.

pelagia.com
+5 more records
Core offering1 text field

Pelagia AS processes and refines pelagic fish (herring, mackerel, capelin, silversmelt) into fresh, frozen, and marinated seafood products, fishmeal and marine oils for aquaculture feed, and ultra-concentrated omega-3 ingredients (including VLC-PUFA) for dietary supplements and pharmaceuticals under the EPAX brand. Operating across 14+ processing facilities in Norway and Northern Europe with a 100% fish utilization, zero-waste model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Pro-Allo fishmeal reduces vulnerable fish by up to 86% compared to standard fishmeal in seabass trials
+5 more records
Product overview1 text field

Pelagia AS operates three integrated divisions: Pelagia Food (14 processing facilities processing pelagic fish into fresh, frozen, and marinated products including herring, mackerel, capelin, and silversmelt); Pelagia Feed (fishmeal, marine oils, and protein concentrates including Pro-Allo meal and H-Oil® Salmon Oil for aquaculture and animal feed); and Pelagia Health/Epax (premium marine lipid ingredients for dietary supplements and pharmaceuticals under EPAX® brand, including EPAX® Evolve 05 as the world's first VLC-PUFA product and EPAX® Cetoleic 2040). The company processes 100% of raw materials with zero waste philosophy across operations in Norway, Denmark, Ireland, and UK.

Product and service2 records
1Pelagia Food
CategorySeafood products
2Pelagia Feed
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Project partner in high-temperature heat pump and superheated steam drying technology for energy-efficient fishmeal production. Collaboration focused on industrial decarbonization at Måløy facility with technology capable of reducing energy use by 70%.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Research partner in SUSHEAT project developing smart waste heat recovery and thermal energy storage technologies. SINTEF contributing expertise in high-temperature heat pump systems for industrial decarbonization.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-21
Description

Project partner in high-temperature heat pump technology for fishmeal production. Contributing to development of energy-efficient drying solutions using superheated steam technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-07
Description

Pelagia acquired 100% of the shareholding in Ideal Foods Limited and its subsidiaries, including Ideal Nutritional Foods. Ideal Foods is headquartered in Cornwall, UK, specializing in fish, shellfish and co-products trading, with a subsidiary supplying fish products for leading baby food producers. Pelagia intends to develop synergies while maintaining continuity of service.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-02-01
Description

Pelagia first became majority shareholder (February 2024) then 100% owner (June 2024) of Blue Ocean Technology. Company develops technical solutions for dewatering, concentration and drying of aquaculture sludge. Integration provides comprehensive sludge handling solutions for aquaculture industry.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Lead partner in EU-funded AQUABIOPRO project focused on bringing proteins and bioactive nutrients from fish processing by-products into the food chain through nutritional supplements.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Danish fishmeal and fish oil producer headquartered in Nyborg. Highly comparable as a Northern European marine protein and oil manufacturer serving aquaculture feed markets—direct overlap with Pelagia Feed.

TypeBroad incumbent
Description

Global nutrition and health ingredient giant with significant omega-3 (DHA/EPA) portfolio via Martek acquisition. Competes with Pelagia Health in high-concentration omega-3 ingredients across nutraceuticals and infant nutrition.

TypeBroad incumbent
Description

UK-listed specialty ingredient company with health care and omega-3 capabilities (Incromega range). Competes with Pelagia Health/Epax in triglyceride-form omega-3 concentrates for supplements and pharma.

TypeDirect peer
Description

Dutch specialty fish oil refiner producing crude, refined, and hydrogenated fish oils for feed and food applications. Comparable to Pelagia's marine oil and feed ingredient business.

TypeDirect peer
Description

Norwegian krill-based marine ingredient company producing omega-3 concentrates for nutraceuticals. Closest like-for-like comparison given Norwegian base, marine-sourced omega-3 focus, and similar ingredient-supplier business model to Pelagia Health/Epax.

TypeDirect peer
Description

Specialist in omega-3 concentrates and fatty acid formulations for nutraceuticals and pharmaceuticals. Direct overlap with Epax in Pelagia Health for high-concentration EPAX/DHA ingredients and customized lipid formulations.

TypeDirect peer
Description

Norwegian marine ingredients company producing salmon-derived protein and oils for nutraceuticals. Comparable end-market focus and Norwegian supply base to Pelagia's Health and Feed divisions.

TypeBroad incumbent
Description

Global chemicals and nutrition giant with omega-3 ingredients (formerly BASF Pronova) and broad animal nutrition portfolio. Competes with Pelagia Health on omega-3 ingredients across human and animal nutrition.

TypeDirect peer
Description

Norwegian fish oil refiner based in Kristiansund producing omega-3 oils for human nutrition. Similar Nordic raw material base and overlapping product portfolio with Pelagia Health/Feed marine oils.

TypeBroad incumbent
Description

Global aquafeed giant and significant buyer of fishmeal and marine proteins. Overlaps with Pelagia's feed customers and competes through integrated aquaculture solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pelagia AS

Seafood Processingpelagia.com

Pelagia AS is a privately held Norwegian seafood processor with three integrated divisions: Food (14 pelagic fish processing facilities), Feed (fishmeal and marine oils), and Health (EPAX omega-3 concentrates). It serves B2B customers across fisheries, aquaculture, food processing, and nutraceutical industries in five countries.

What Pelagia AS does

Pelagia AS is a privately held Norwegian seafood company headquartered in Bergen that processes pelagic fish and manufactures fishmeal, marine oils, and protein concentrates across three integrated divisions: Pelagia Food (14 processing facilities producing fresh, frozen, and marinated herring, mackerel, capelin, and silversmelt for export); Pelagia Feed (fishmeal, marine oils, and protein concentrates for aquaculture and animal feed, including Pro-Allo meal and H-Oil Salmon Oil); and Pelagia Health (premium marine lipid ingredients under the EPAX brand for dietary supplements and pharmaceuticals, including the 2025-launched EPAX Evolve 05, the world's first commercially available VLC-PUFA product). The company applies a 100% fish utilization, zero-waste philosophy and operates from 46 locations across five countries (Norway, Denmark, UK, Ireland, and additional markets) with approximately 1,700 employees.

Pelagia's competitive position rests on proprietary process technology including the EQP+Tech molecular distillation platform (maintaining 90%+ triglyceride content without excessive heat or harsh chemicals, backed by data from over a thousand test runs), custom re-esterification with sensors monitoring thousands of data points, Pro-Allo fishmeal with over 32% water-soluble protein content, and high-temperature heat pump drying technology that reduces energy use by approximately 70% at the Måløy facility. Regulatory credentials include US FDA Pharmaceutical Intermediates approval, Norwegian Medicines Agency API production approval, and GMP+ FSA plus MarinTrust certifications across multiple feed products. The company invests in research partnerships (Nofima, SINTEF) and industrial decarbonization collaborations (Enerin, Swedish Exergy).

The business model is B2B wholesale across four primary vertical segments (fisheries, aquaculture, food processing, and health/nutraceutical), with sales managed by regional sales managers in Norway, the UK, and international markets through quote-based pricing. Revenue is generated through one-time license/sale of physical marine ingredient products, with distribution through direct sales channels and global export of seafood products. Capital structure reflects an active acquisition strategy (Ideal Foods in March 2024, Blue Ocean Technology consolidated by June 2024, Fjord Solutions in June 2025) and two consecutive NOK 1,000 million senior unsecured bond issuances in 2024 and 2025 applied for listing on Oslo Børs.

Pelagia AS firmographics

Firmographics
Name
Pelagia AS
Legal name
Pelagia Holding AS
Website
https://pelagia.com
Company type
Private
Operating status
Operating
Headcount range
251–500 employees
Short description
Pelagia AS is a privately held Norwegian seafood processor with three integrated divisions: Food (14 pelagic fish processing facilities), Feed (fishmeal and marine oils), and Health (EPAX omega-3 concentrates). It serves B2B customers across fisheries, aquaculture, food processing, and nutraceutical industries in five countries.
Ownership category
akta.pro rank

Pelagia AS industry classification

Industry
Product category
Seafood Processing
NAICS
Seafood Product Preparation and Packaging (3117)
SIC
Prepared Fresh Or Frozen Fish & Seafoods (2092), Fats & Oils (2070)
akta.pro primary industry
Seafood By-Products & Fishmeal/Fish Oil Processing (Rendering, Hydrolysates, Collagen) (AFANADAJ)
akta.pro secondary industries
Finfish Feed (Salmonids, Trout, Sea Bass/Bream, Tilapia, Catfish) (AFADADAA), Aquaculture Feed & Nutrition (HLAMAHAF), Smoked, Cured & Salted Seafood (Lox, Kippers, Bacalao) (AFANADAF)

Keywords

  • Pelagic fish processing
  • Fishmeal production
  • Marine oil refining
  • Omega-3 concentrates
  • Aquaculture feed ingredients

Where Pelagia AS is headquartered

Location

Headquarters

HQ city
Bergen
HQ country
Norway
HQ region
Europe

Offices8 records

Markets served

Pelagia AS business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Supply Chain, Infrastructure, Technology or R&D

Revenue model

  1. Pelagia Food - Pelagic Seafood Products: Processing and export of pelagic fish including herring, mackerel, capelin, and silversmelt in fresh, frozen, and marinated forms. 14 processing facilities in Norway and Northern Europe ensuring freshness and high quality.
  2. Pelagia Feed - Fishmeal and Marine Oils: Production of fish meal, marine oils, and protein concentrates for aquafeed and animal feed applications. Includes Pro-Allo meal, marine protein, and liquid protein products for aquaculture.
  3. Pelagia Health - EPAX Omega-3 Products: Premium-quality marine ingredients for dietary supplements and pharmaceuticals under the EPAX brand. Includes ultra-concentrated omega-3, VLC-PUFA products, and specialty fatty acid ingredients for nutraceutical applications.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Pelagia AS product offering

Product offering

Core offering

Pelagia AS processes and refines pelagic fish (herring, mackerel, capelin, silversmelt) into fresh, frozen, and marinated seafood products, fishmeal and marine oils for aquaculture feed, and ultra-concentrated omega-3 ingredients (including VLC-PUFA) for dietary supplements and pharmaceuticals under the EPAX brand. Operating across 14+ processing facilities in Norway and Northern Europe with a 100% fish utilization, zero-waste model.

Product overview

Pelagia AS operates three integrated divisions: Pelagia Food (14 processing facilities processing pelagic fish into fresh, frozen, and marinated products including herring, mackerel, capelin, and silversmelt); Pelagia Feed (fishmeal, marine oils, and protein concentrates including Pro-Allo meal and H-Oil® Salmon Oil for aquaculture and animal feed); and Pelagia Health/Epax (premium marine lipid ingredients for dietary supplements and pharmaceuticals under EPAX® brand, including EPAX® Evolve 05 as the world's first VLC-PUFA product and EPAX® Cetoleic 2040). The company processes 100% of raw materials with zero waste philosophy across operations in Norway, Denmark, Ireland, and UK.

Differentiator

Problem solved

Functional benefit

Brands

  • Pro-Allo Meal: A breakthrough fishmeal optimized to improve feed efficiency, fish health, and survival rates in aquaculture, with over 32% water-soluble protein content.
  • EPAX
  • H-Oil Salmon Oil
  • Pro-AquaPept
  • H-pro Salmon Protein Concentrate
  • FPC Fish Protein Concentrate

Products and services

  • Pelagia Food
  • Pelagia Feed

Quantifiable outcome

  • Pro-Allo fishmeal reduces vulnerable fish by up to 86% compared to standard fishmeal in seabass trials
  • +5 more outcomes

Companies that use Pelagia AS

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Pelagia AS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Pelagia AS partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • EnerincoreStrategic or Co-development Partner · 21 January 2026Project partner in high-temperature heat pump and superheated steam drying technology for energy-efficient fishmeal production. Collaboration focused on industrial decarbonization at Måløy facility with technology capable of reducing energy use by 70%.
  • SINTEFcoreStrategic or Co-development Partner · 21 January 2026Research partner in SUSHEAT project developing smart waste heat recovery and thermal energy storage technologies. SINTEF contributing expertise in high-temperature heat pump systems for industrial decarbonization.
  • Swedish ExergycoreStrategic or Co-development Partner · 21 January 2026Project partner in high-temperature heat pump technology for fishmeal production. Contributing to development of energy-efficient drying solutions using superheated steam technology.
  • Ideal Foods LimitedcoreStrategic or Co-development Partner · 7 March 2024Pelagia acquired 100% of the shareholding in Ideal Foods Limited and its subsidiaries, including Ideal Nutritional Foods. Ideal Foods is headquartered in Cornwall, UK, specializing in fish, shellfish and co-products trading, with a subsidiary supplying fish products for leading baby food producers. Pelagia intends to develop synergies while maintaining continuity of service.
  • Blue Ocean Technology AScoreStrategic or Co-development Partner · 1 February 2024Pelagia first became majority shareholder (February 2024) then 100% owner (June 2024) of Blue Ocean Technology. Company develops technical solutions for dewatering, concentration and drying of aquaculture sludge. Integration provides comprehensive sludge handling solutions for aquaculture industry.
  • NofimaminorStrategic or Co-development Partner · 1 January 2023Lead partner in EU-funded AQUABIOPRO project focused on bringing proteins and bioactive nutrients from fish processing by-products into the food chain through nutritional supplements.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Pelagia AS competitors and assessment

Company assessment

Direct peers

  • TripleNine: Danish fishmeal and fish oil producer headquartered in Nyborg. Highly comparable as a Northern European marine protein and oil manufacturer serving aquaculture feed markets—direct overlap with Pelagia Feed.
  • Marvesa: Dutch specialty fish oil refiner producing crude, refined, and hydrogenated fish oils for feed and food applications. Comparable to Pelagia's marine oil and feed ingredient business.
  • Aker BioMarine: Norwegian krill-based marine ingredient company producing omega-3 concentrates for nutraceuticals. Closest like-for-like comparison given Norwegian base, marine-sourced omega-3 focus, and similar ingredient-supplier business model to Pelagia Health/Epax.
  • KD Pharma Group: Specialist in omega-3 concentrates and fatty acid formulations for nutraceuticals and pharmaceuticals. Direct overlap with Epax in Pelagia Health for high-concentration EPAX/DHA ingredients and customized lipid formulations.
  • Hofseth BioCare: Norwegian marine ingredients company producing salmon-derived protein and oils for nutraceuticals. Comparable end-market focus and Norwegian supply base to Pelagia's Health and Feed divisions.
  • GC Rieber Oils: Norwegian fish oil refiner based in Kristiansund producing omega-3 oils for human nutrition. Similar Nordic raw material base and overlapping product portfolio with Pelagia Health/Feed marine oils.

Broad incumbents

  • DSM-Firmenich: Global nutrition and health ingredient giant with significant omega-3 (DHA/EPA) portfolio via Martek acquisition. Competes with Pelagia Health in high-concentration omega-3 ingredients across nutraceuticals and infant nutrition.
  • Croda International: UK-listed specialty ingredient company with health care and omega-3 capabilities (Incromega range). Competes with Pelagia Health/Epax in triglyceride-form omega-3 concentrates for supplements and pharma.
  • BASF: Global chemicals and nutrition giant with omega-3 ingredients (formerly BASF Pronova) and broad animal nutrition portfolio. Competes with Pelagia Health on omega-3 ingredients across human and animal nutrition.
  • Cargill Aqua Nutrition: Global aquafeed giant and significant buyer of fishmeal and marine proteins. Overlaps with Pelagia's feed customers and competes through integrated aquaculture solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Pelagia AS compliance and trust

Trust signal

Compliance9 records

Pelagia AS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pelagia AS leadership team

Management profile

Number of profiles

Profiles8 records

Pelagia AS subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Pelagia AS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pelagia AS M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pelagia AS

What does Pelagia AS do?

Pelagia AS processes and refines pelagic fish (herring, mackerel, capelin, silversmelt) into fresh, frozen, and marinated seafood products, fishmeal and marine oils for aquaculture feed, and ultra-concentrated omega-3 ingredients (including VLC-PUFA) for dietary supplements and pharmaceuticals under the EPAX brand. Operating across 14+ processing facilities in Norway and Northern Europe with a 100% fish utilization, zero-waste model.

Is Pelagia AS a public or private company?

Pelagia AS is a private company. It is classified as unknown and is currently operating.

When was Pelagia AS founded?

Pelagia AS was founded in -1. It employs 251 to 500 people.

Where is Pelagia AS based?

Pelagia AS is headquartered in Bergen, Norway, in the Europe region.

How does Pelagia AS make money?

Three revenue lines are on record. Pelagia Food - Pelagic Seafood Products are the primary driver. The others are pelagia Feed - Fishmeal and Marine Oils and pelagia Health - EPAX Omega-3 Products.

Who are Pelagia AS's main competitors?

Direct peers on record are TripleNine, Marvesa, Aker BioMarine, KD Pharma Group, Hofseth BioCare and GC Rieber Oils. Broad incumbents are DSM-Firmenich, Croda International, BASF and Cargill Aqua Nutrition.

Does Pelagia AS have an API?

No public API is recorded for Pelagia AS.

What industry is Pelagia AS in?

Pelagia AS's product category is Seafood Processing. Its primary akta.pro industry code is AFANADAJ, Seafood By-Products & Fishmeal/Fish Oil Processing (Rendering, Hydrolysates, Collagen), with a secondary code of AFADADAA, Finfish Feed (Salmonids, Trout, Sea Bass/Bream, Tilapia, Catfish). Its NAICS code is 3117 and its SIC code is 2092.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Scotland NewsMajor Scottish islands employer sees profits almost doublePelagia Shetland fish factory reported turnover of £86 million and profit after tax of £6 million for the year ended December 31, 2025, up from £80 million and £3.3 million the prior year. The company attributed the rise to favourable market forces and cited risks including supply and customer loss.PR NewswireOmega-3 Market worth $8.73 billion by 2031- Exclusive Report by MarketsandMarkets™According to MarketsandMarkets™, the global omega-3 market is projected to grow from USD 4.88 billion in 2026 to USD 8.73 billion by 2031, at a compound annual growth rate of 12.3%, driven by increasing consumer awareness of the health benefits of omega-3 fatty acids and rising prevalence of chronic diseases. North America is estimated to account for the largest regional market share at 37% in 2026, while the infant formula application segment is projected to grow at the highest CAGR of 13.6% during the forecast period. Key industry players including Pelagia AS, Corbion, DSM-Firmenich, and BASF SE are actively investing in new product launches and production capacity expansions to capitalize on the growing demand, particularly for docosahexaenoic acid (DHA)-based products.openPR.comOmega-3 Supplements Market to Reach US$ 18.72 Billion by 2033 Driven by Rising Health Awareness, Preventive Healthcare Trends, and Growing Demand for Nutraceuticals & Functional SupplementsDataM Intelligence published a market research report projecting the global omega-3 supplements market to grow from US$9.00 billion in 2025 to US$18.72 billion by 2033, at a CAGR of 9.59%, driven by rising health awareness, preventive healthcare trends, and increasing demand for nutraceuticals and functional supplements. The report details competitive dynamics among key players including Nordic Naturals, NOW Foods, DSM-Firmenich, BASF, KD Pharma Group, and Pelagia AS, covering new product launches, R&D in algae-based omega-3, and strategic expansions in manufacturing capabilities. Market segmentation shows fish oil dominates (55%) by source, capsules/softgels lead (60%) by form, EPA & DHA accounts for 65% by type, with cardiovascular health as the primary application (30%), while North America holds the largest regional share at 35%.